Beckman Coulter Life Sciences Appoints Michelle Caron Vice President Of Finance And Chief Financial Officer
Michelle’s appointment is a move within parent company Danaher where she has spent the past 10 years in roles of increasing responsibility at two divisions, most recently as Group Financial Officer for the Food & Beverage, Laboratory, and Medical business units at Pall. Prior to her positions at Pall, Michelle served as the Chief Financial Officer at Phenomenex.
“We’re incredibly fortunate to have someone of Michelle Caron’s caliber join our team and lead several key initiatives for 2021 and beyond,” said Greg Milosevich, President of Beckman Coulter Life Sciences. “Our ‘best team wins’ philosophy is especially true when we can promote from within, and we’re pleased to be able to do so within Danaher and with someone as accomplished as Michelle.”
Prior to joining Danaher, Michelle worked at Philips Healthcare and Stryker Biotech in finance and controller roles. She is a Certified Public Accountant and earned her MBA from Southern Connecticut State University and her BSc in Accounting from Central Connecticut State University.
Michelle started June 21 and will be based in the San Jose, California office.